Skip to search formSkip to main contentSkip to account menu

levoxadrol

Known as: l-2,2-diphenyl-4-(2-piperidyl)-1,3-dioxolane 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AnalgesicsDioxolanesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1996
Highly Cited
1996
Dizocilpine-like Discriminative Stimulus Effects of Low-affinity Uncompetitive NMDA Antagonists
Highly Cited
1987
Highly Cited
1987
Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
We have reported previously that phencyclidine (PCP) antagonizes N-methyl-D-aspartate (NMDA)-induced release of dopamine and… 
1986
1986
Enhancement of brain calcium antagonist binding by phencyclidine and related compounds
Highly Cited
1985
Highly Cited
1985
Anticonvulsant properties of phencyclidine-like drugs in mice.
Highly Cited
1985
Highly Cited
1985
Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Representatives from several chemical classes known to share behavioral properties with phencyclidine [(1-phenylcyclohexyl… 
Highly Cited
1984
Highly Cited
1984
Phencyclidine receptors in rat brain cortex.
1984
1984
The effect of the dioxolanes on amino acid induced excitation in the mammalian spinal cord
Highly Cited
1983
Highly Cited
1983
Characterization of specific sigma opiate/phencyclidine (PCP)-binding sites in the human brain.
Highly Cited
1982
Highly Cited
1982
Stereospecific binding of 3H-phencyclidine in brain membranes.
1982
1982
Differing stereospecificities distinguish opiate receptor subtypes.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)